
|Articles|September 21, 2006
PhRMA Names New Chairman
Author(s)Pharmaceutical Technology Editors
Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America upon the resignation of Peter R. Dolan.
Advertisement
Washington, DC (Sept. 15)-Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America (PhRMA,
Sharer emphasized PhRMA's commitment to “drive American innovation, confront the toughest healthcare problems, deliver great value to patients, and make medicines available to patients who need them.” He added that PhRMA will “continue partnering with patients, physicians, and other healthcare stakeholders to achieve these goals.”
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
European Biotechs Reshaping Respiratory Disease
2
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
3
Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts
4
Technology Transfer Between Contractors, A Panel Discussion, Part 1
5




